Tentarix Biotherapeutics is Drug Discovery in United States that focus on therapeutics leverages business. Founded in 2020. They cover business area such as developer, innovative protein therapeutic, novel biologic, logic-gate activity, synthetic biology, multispecific bind molecule, combine bioactivitie, fully human antibody variable domain, pharmaceutical company, multi-specific investigational drug, exist cancer.
2020
( 4 years old in 2024 )
Therapeutics Leverages
-
10355 Science Center Drive
Suite 120
San Diego, CA 92121
United States
Private
developerinnovative protein therapeuticnovel biologiclogic-gate activitysynthetic biologymultispecific bind moleculecombine bioactivitiefully human antibody variable domainpharmaceutical companymulti-specific investigational drugexist cancer
* We use standard office opening hours in near Tentarix Biotherapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Tentarix Biotherapeutics is Drug Discovery business from United States that founded in 2020 (4 years old in 2024), Tentarix Biotherapeutics business is focusing on Therapeutics Leverages.
Tentarix Biotherapeutics headquarter office and corporate office address is located in 10355 Science Center Drive Suite 120 San Diego, CA 92121 United States.
Tentarix Biotherapeutics was founded in United States.
In 2024, Tentarix Biotherapeutics is currently focus on therapeutics leverages sector.
Above is snippet of Google Trends for "therapeutics leverages" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Tentarix Biotherapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.